OC.12.2 THE REAL-WORLD LONG-TERM EFFECTIVENESS OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASES: A SINGLE CENTER OBSERVATIONAL STUDY. (25th March 2019)